The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia (0597-10-HMO)

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified January 2012 by Hadassah Medical Organization
Sponsor:
Information provided by (Responsible Party):
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01509170
First received: January 10, 2012
Last updated: NA
Last verified: January 2012
History: No changes posted

January 10, 2012
January 10, 2012
February 2012
January 2015   (final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia
Observational Cohort Study- The Clinical and Laboratory Characteristics of Recurrent Drug- Related

The aim of this study is to identify factors associated with hyponatremia among patients hospitalized in the internal medicine ward. Consequtive patients hospitalized because of hyponatremia will be recruited. Follow up will include clinical factors such as background diseases, complete drug history, blood tests including Biochemistry tests (Sodium, renal function), endocrinological evaluation, thyroid function tests, cortisol,urinary sodium on addmition. One month following discharge follow up Sodium level will be taken.

Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Consequtive patients hospitalized to the internal medicine ward due to hyponatremia

  • Hyponatremia
  • SIADH
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
500
January 2017
January 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients hospitalized to the internal medicine ward due to hyponatremia

Exclusion Criteria:

  • None
Both
Not Provided
No
Israel
 
NCT01509170
0597-10-HMO, 0597
No
Hadassah Medical Organization
Hadassah Medical Organization
Not Provided
Principal Investigator: Mordechai Muszkat, MD Hadassah Medical Organization
Hadassah Medical Organization
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP